Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)
149 Downloads (Pure)


In myocardial ischemia/reperfusion injury, the innate immune and subsequent inflammatory responses play a crucial role in the extension of myocardial damage. Toll-like receptor 9 (TLR9) is a critical receptor for recognizing unmethylated CpG motifs that mitochondria contain in their DNA, and induces inflammatory responses. The aim of this study was to elucidate the role of TLR9 in myocardial ischemia/reperfusion injury.

Isolated hearts from TLR9-deficient and control wild-type mice were subjected to 35 min of global ischemia, followed by 60 min of reperfusion with Langendorff apparatus. Furthermore, wild-type mouse hearts were infused with DNase I and subjected to ischemia/reperfusion.

Ablation of TLR9-mediated signaling pathway attenuates myocardial ischemia/reperfusion injury and inflammatory responses, and digestion of extracellular mitochondrial DNA released from the infarct heart partially improved myocardial ischemia/reperfusion injury with no effect on inflammatory responses. TLR9 could be a therapeutic target to reduce myocardial ischemia/reperfusion injury.
Original languageEnglish
Pages (from-to)442-447
JournalBiochemical and Biophysical Research Communications
Issue number3
Early online date31 May 2019
Publication statusPublished - 30 Jul 2019


  • Inflammation
  • Langendorff-perfused mouse heart
  • Mitochondrial DNA
  • Myocardial ischemia/reperfusion injury
  • Toll-like receptor 9


Dive into the research topics of 'Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice'. Together they form a unique fingerprint.

Cite this